An interventional study of Temporary Peripheral Nerve Stimulation System in Neuropathy;Peripheral, sponsored by Epineuron Technologies Inc.. Recruiting at 2 sites in Canada. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-08.
Sponsored by Epineuron Technologies Inc. · Not applicable, Interventional, and Other
A novel temporary peripheral nerve stimulation system that delivers electrical stimulation therapy in a cubital tunnel release model will be evaluated for feasibility.
73 studies on the registry are indexed under Neuritis; 20 are open to participants now.
This study's planned enrollment of 26 is below the median of 48 across 51 interventional studies indexed under Neuritis.
Browse Neuritis studies →Epineuron Technologies Inc. is the lead sponsor of 3 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Standard of care plus therapy, which consists of a single, 1 hour dose of electrical stimulation.
Device: Temporary Peripheral Nerve Stimulation System
Standard of care only.
Single use medical device. Therapy consists of single, 1 hour dose of electrical stimulation.
Eligibility Rate
Evaluation of study feasibility through the number of participants who pass all pre-operative screening eligibility criteria
Time frame: 1.5 years
Recruitment Rate
Evaluation of study feasibility through the number of participants who complete informed consent and are randomized into a study arm
Time frame: 1.5 years
Retention Rate
Evaluation of study feasibility through the number of participants who complete all study activities
Time frame: 1.5 years
Electromyography (EMG) Denervation Absence/Presence
Measurement of electrical activity of a muscle
Time frame: 1.5 years
Nerve Conduction Study (NCS)
Measurement of speed of electrical impulse through a nerve
Time frame: 1.5 years
Semmes-Weinstein Monofilament Test
Evaluation of sensory recovery through the measurement of a pressure detection threshold
Time frame: 1.5 years
Static Two-Point Discrimination
Evaluation of sensory recovery through the measurement of the threshold of discrimination
Time frame: 1.5 years
Grip strength
Evaluation of functional recovery through the measurement of maximum grip strength
Time frame: 1.5 years
Pinch strength
Evaluation of functional recovery through the measurement of pinch strength
Time frame: 1.5 years
Patient Rated Ulnar Nerve Evaluation (PRUNE)
Evaluation of pain and quality of life through patient-reported questionnaire where lower scores indicate lower pain and better quality of life related to the injury
Time frame: 1.5 years
Plan to share: No
No publications or documents are linked to this record.
Started Nov 2023 (actual). Primary completion is estimated for Dec 2025, 25 months after the start.
Of 23 interventional studies with no phase under Neuritis, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 31. This study's planned 25 months is close to that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Epineuron Technologies Inc.